Search results for: 'drug ad diseas'
- Related search terms
- drug 01 00 00 00
- drug discovery ad earth development outsourcing market
- drug discovery ad east development outsourcing market
- diseas solution market research methodology greater china
- diseas destructive services market research
-
16 Jun 2020  |  Global  |  Technology Research
Material Technologies Facilitating Targeted Drug Delivery
Nanomaterials are Gaining Research Focus for Targeted Drug Delivery
Targeted drug delivery is gaining traction owing toward significant demand for improvement in the drug delivery efficiency as well as the need to mitigate potential side-effects, which can occur due to drug accumulation. The concept of targeted drug delivery is not new, the technology started gaining pace with the advent of nanotechnology and bioco...
$4,950.00 -
26 Jun 2019  |  Global  |  Technology Research
Novel Technologies Driving Infectious Disease Management
Upcoming Technologies for Infectious Disease Diagnosis
This research service covers emerging diagnostic technologies that can transform infectious disease management. CRISPR-based diagnostics: CRISPR (clustered regularly interspaced short palindromic repeats) can deliver rapid, portable and accurate diagnostics tests for field applications. This reports deals with two major US-based players developing...
$4,950.00 -
27 Apr 2023  |  Global  |  Technology Research
Technology Innovations and Growth Opportunities in Inhaled Therapeutics
Nanoparticle-based Formulation to Drive Transformational Growth Across Inhaled Vaccines and Monoclonal Antibodies
Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for inhalation delivery, but recent R&D and increased interest in inhalable COVID-19 vaccines have led to a shift toward inhalabl...
$4,950.00 -
13 Oct 2021  |  Global  |  Technology Research
Global Neurological Therapies Growth Opportunities
Need for Effective Palliative Management Driving Technology Advances in Neurological Disease Drug Development
Neurological diseases refer to disorders of the brain, nerves, and spinal cord that lead to structural, biochemical, or electrical complications in the body. Major causes of neurological disorders include brain, spinal cord, or nerve injury; genetic disorders; congenital abnormalities; infections; and lifestyle. Neurological diseases include an ext...
$4,950.00 -
02 Dec 2019  |  North America  |  Market Research
The Challenges and Best Practices for Inserting Ads into OTT Downloadable Videos
AVOD Providers are Unsure About Integrating into an Ad-supported Business Model
The importance of download as a feature within OTT services and how it may be a big business opportunity for AVOD providers cannot be overstated. But this will only hold true if the technology can work seamlessly with existing apps and ad-based revenue models. More OTT services, both AVOD and SVOD, must start including downloads as an option, to en...
$1,500.00 -
30 Mar 2016  |  Global  |  Technology Research
Next Generation Diabetes Therapy and Drug Delivery Technologies
Global Diabetes Epidemic Adds Urgency to R&D Initiatives, Inhalable and Transdermal Delivery on Upward Trajectory
Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...
$4,950.00 -
05 Oct 2018  |  North America  |  Market Research
US Point-of-Care Testing Infectious Disease Market, Forecast to 2022
CLIA Waived Molecular POCT, Coupled with Upcoming Diseases Like Sepsis, Lyme Disease, New Strains of Influenza—H1, H3, and H7, will Drive Growth
Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...
$1,500.00 -
18 Nov 2022  |  Europe  |  Market Research
European Anaerobic Digestion (AD) and Biogas Production Growth Opportunities
The EU’s Green Taxonomy and the REPowerEU Plan have Put the Spotlight on Long-term Investments in the Sustainability of Renewable Natural Gas (RNG) Production through AD
Several European countries, including Germany, the United Kingdom, and Denmark, are at the forefront of leveraging the potential of biogas produced through the anaerobic digestion (AD) of energy crops, agricultural waste, organic waste, and sewage sludge. Subsidies and incentives are the key growth drivers. As part of its Net Zero by 2050 Strategy,...
$2,450.00 -
02 May 2023  |  Global  |  Technology Research
Technology Advances in Senolytics
Innovative Drug Development Culture Working to Prolong Health Spans and Eliminate Aging Cells
Senolytics is a relatively new field of development that falls under the broad category of senotherapeutics, along with senomorphics and senostatics. Although nascent, the field could address the root causes of most chronic conditions brought on by aging as it clears senescent cells that have ceased to multiply (and ideally are eliminated from the ...
$4,950.00 -
28 Sep 2018  |  North America  |  Technology Research
Gene Editing and Gene Therapy Breakthroughs to Propel Mainstream Disease Treatments
A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present
The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...
$4,950.00